Clinical Trial Update: A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a new drug for benign prostatic hyperplasia versus placebo has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• A New Drug for BPH

Snippet

Sponsor: Watson Pharmaceuticals | Conditions: Benign Prostatic Hyperplasia (BPH) | Phase 3 | Status: COMPLETED | Results posted: 2009-12-03